Dr. Peter Lelkes and OrthoMend Inc. team up

 

Bioengineering licenses device for regenerative orthopedicsTemple University's College of Engineering will be licensing orthopedic device technology to OrthoMend Inc., the company announced. The Philadelphia-based start-up will use research from Temple's Bioengineering Department to create novel absorbable bone fixation and regenerative repair technologies for commercial use.

 

Using nanodiamond screws, this technology will improve healing times and cost less. Dr. Peter Lelkes, who recently became Chair of Bioengineering and Director of the Institute for Regenerative Medicine and Engineering at Temple, compares this to biodegradable sutures. "The innovation here is that you can increase both the mechanical strength and the ductility, so they don't break off when you insert them," Lelkes said.

Dr. Lelkes notes this is a key partnership for the growing department. "The licensing of our invention to OrthoMend Research is an important milestone in our efforts to translate our basic research from the bench to the bedside and will, without a doubt, result in commercial products that will benefit patients around the globe," Lelkes said.

The partnership adds more research funding to the department, founded in 2012. Research among the faculty and students on grants from the National Institute of Health, National Science Foundation, and a new commission from the Department of Defense announced in November.

For the Temple News piece click here.
Read more in Orthopedics This Week.